Pure Global

Ultra-high-caloric, Fatty Diet in ALS - Trial NCT06280079

Access comprehensive clinical trial information for NCT06280079 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Ulm and is currently Not yet recruiting. The study focuses on Amyotrophic Lateral Sclerosis. Target enrollment is 392 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06280079
Not yet recruiting
dietary supplement
Trial Details
ClinicalTrials.gov • NCT06280079
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ultra-high-caloric, Fatty Diet in ALS
Efficacy, Safety, and Tolerability of Ultra-high-caloric, Fatty Diet (UFD) in Amyotrophic Lateral Sclerosis (ALS)

Study Focus

Ultra-high-caloric fatty diet

Interventional

dietary supplement

Sponsor & Location

University of Ulm

Aachen,Berlin,Bochum,Bonn,Dresden,Erlangen,Essen,Göttingen,Halle,Hannover,Jena,Kassel,Kempten,Leipzig,Lübeck,Mannheim,Munich,Münster,Regensburg,Rostock,Ulm,Wiesbaden,Würzburg, Germany

Timeline & Enrollment

N/A

May 01, 2024

May 01, 2027

392 participants

Primary Outcome

Survival

Summary

This study aims at evaluating efficacy and tolerability of an ultra-high-caloric, fatty diet
 (UFD) compared to placebo in patients with amyotrophic lateral sclerosis (ALS).

ICD-10 Classifications

Neuralgic amyotrophy
Motor neuron disease
Other degenerative diseases of the nervous system
Other degenerative disorders of nervous system in diseases classified elsewhere
Multiple sclerosis

Data Source

ClinicalTrials.gov

NCT06280079

Non-Device Trial